Studies have shown that in bone marrow chimeras with ATG5-deficient donor cells, there is a significant increase in IFN-γ and TNFα-producing CD8+ T cells in tumor-infiltrating lymphocytes, leading to improved tumor control (59). Here, ATG5 is linked to neoplasm.